‘Sleeper Issue:’ How Part B Drugs May Be Impacted By Medicare Part D Redesign

 
• By Sarah Karlin-Smith

If changes to stand-alone Part D plans mandated by the IRA drive a switch to MA plans, the changing enrollment could drive more uptake of physician-administered drugs – but also more utilization management.

woman sleeping in a bed
Changes to Part D and a shift to MA could offer some benefits for Part B drugs • Source: Shutterstock

More from Medicare

More from Government Payers